Original Research
Published on 21 Apr 2017
Use of Lentiviral Particles As a Cell Membrane-Based mFasL Delivery System for In Vivo Treatment of Inflammatory Arthritis
in Vaccines and Molecular Therapeutics
- 5,734 views
- 4 citations
Original Research
Published on 21 Apr 2017
in Vaccines and Molecular Therapeutics
Review
Published on 30 Apr 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Mini Review
Published on 08 Apr 2014
in Plant Physiology
Mini Review
Published on 04 Jan 2024
in Membrane Pores, Channels, and Transporters
Perspective
Published on 31 May 2021
in Chemical Biology
Original Research
Published on 25 Oct 2018
in Microbial Physiology and Metabolism
Original Research
Published on 14 May 2018
in Virology
Review
Published on 11 Jan 2024
in Membrane Traffic and Organelle Dynamics
Original Research
Published on 24 Nov 2023
in Molecular Innate Immunity
Original Research
Published on 15 Jul 2020
in Mitochondrial Research
Review
Published on 02 Oct 2025
in B Cell Biology
Review
Published on 23 Jul 2021
in Cancer Genetics and Oncogenomics
Review
Published on 26 Sep 2013
in Clinical and Translational Physiology
Review
Published on 12 Mar 2021
in Cellular Biochemistry
Review
Published on 09 Apr 2018
in Pediatric Nephrology
Review
Published on 30 May 2025
in Lipids, Membranes and Membranous Organelles